Filters
reset allTests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Labcorp Genetics (formerly Invitae) LabCorp United States | 160 | 62 |
|
Invitae 78 Gene Actionable Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 220 | 75 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 90 | 90 |
|
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States | 88 | 90 |
|
Ambry Genetics United States | 94 | 90 |
|
Ambry Genetics United States | 86 | 89 |
|
Comprehensive Panel for Individualized Cancer Threatment GeneKor MSA Greece | 15 | 52 |
|
Hereditary Gastric Cancer Panel Genetic Services Laboratory University of Chicago United States | 10 | 19 |
|
PreventionGenetics, part of Exact Sciences United States | 122 | 117 |
|
Piebaldism and Familial Gastrointestinal Stromal Tumors (GISTs) via the KIT Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Familial Gastrointestinal Stromal Tumors (GISTs) via the PDGFRA Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
GeneDx United States | 103 | 82 |
|
Primary Antibody Deficiency NGS Panel Fulgent Genetics United States | 102 | 37 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Severe Combined Immunodeficiency NGS Panel Fulgent Genetics United States | 330 | 90 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Neurotransmitter Metabolism Deficiency NGS Panel Fulgent Genetics United States | 85 | 101 |
|
Hereditary Paraganglioma/Pheochromocytoma Panel Baylor Genetics United States | 21 | 9 |
|
Baylor Genetics United States | 41 | 13 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.